DrugPatentWatch Database Preview
Details for Patent: 7,682,634
» See Plans and Pricing
Which drugs does patent 7,682,634 protect, and when does it expire?
Patent 7,682,634 protects EMBEDA and is included in one NDA.
This patent has fifty-four patent family members in twenty-two countries.
Summary for Patent: 7,682,634
| Title: | Pharmaceutical compositions |
| Abstract: | Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal coat forms a layer physically separating the antagonist from the agonist from one another. Methods for manufacturing such a pharmaceutical composition are also provided. |
| Inventor(s): | Matthews; Frank (Edison, NJ), Boehm; Garth (Westfield, NJ), Tang; Lijuan (Flemington, NJ), Liang; Alfred (Edison, NJ) |
| Assignee: | Alpharma Pharmaceuticals, LLC (Bridgewater, NJ) |
| Application Number: | 12/399,923 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; |
Drugs Protected by US Patent 7,682,634
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022321-001 | Aug 13, 2009 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022321-002 | Aug 13, 2009 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022321-003 | Aug 13, 2009 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022321-004 | Aug 13, 2009 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022321-005 | Aug 13, 2009 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 022321-006 | Aug 13, 2009 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,682,634
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 552829 | Start Trial | |||
| Australia | 2007261451 | Start Trial | |||
| Australia | 2013257508 | Start Trial | |||
| Australia | 2016238844 | Start Trial | |||
| Australia | 2018201915 | Start Trial | |||
| Brazil | PI0714039 | Start Trial | |||
| Canada | 2655835 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
